Treatment failure after substitution of generic pancrelipase capsules.
Haymes
A J
AJ
Levy
R A
RA
D002214:Capsules; D006801:Humans; D008049:Lipase / Q000008:administration & dosage / Q000493:pharmacokinetics*; D010184:Pancreatic Extracts / Q000008:administration & dosage / Q000493:pharmacokinetics*; D020799:Pancrelipase; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D002214:Capsules; D010184:Pancreatic Extracts; D020799:Pancrelipase; D008049:Lipase